That's how much the moderna vaccine really protects you, a new study says
The company has just published new data on how the vaccine is effective over time.
All threeCoronavirus vaccines allowed to use In the United States, it has been very effective in their initial clinical trials. But over time and more people are vaccinated in the real world, we learn more about the effectiveness of these vaccines over time. Moderna has published results of a long six-month study, showing how much the vaccine really protects you half a year after being vaccinated. Read to find out how effective the vaccine remains after six months and for more information on this specific vaccine, checkModerna provoked this reaction in 82% of people, the new study says.
The Moderna vaccine is greater than 90% after six months.
Moderna has published conclusions of the third phase of its Coronavirus Efficiency and Security Study (COVE) on April 13, showing how theThe vaccine remained about six months After the participants received their second dose. According to their conclusions, the Moderna vaccine is still greater than 90% against all cases of COVID and more than 95% effective against serious COVID cases six months after vaccination.
Moderna delivered approximately 132 million doses of its COVID vaccine around the world and researchers observed just over 900 total cases of COVID - which included 100 serious cases - vaccinated participants during the trial until April 9 and more about how the vaccine works, check outDr. Fauci says that's how you can catch Covid even if you're vaccinated.
Moderna already works on reminder fire for emerging variants.
With variants of COVID that continue to emerge and threaten the effectiveness of vaccines, moderna also works on recall shooting. During an appearance on CNBCSafe April 14, CEO of ModernaStéphane Bantel says he hopes to haveshots Designed to target emerging variants available by autumn. Moderna says that this has preclinical data on two variant-specific strengthening vaccine candidates: one against the South African variant B.1.351 and another multivalent booster candidate.
"The new preclinical data on our variant-specific vaccine candidates trust us that we can proactively treat emerging variants," said Bondel in a statement. "Moderna will make as many updates of our Covid-19 vaccine if necessary until the pandemic is under control." And for more reminders, checkThe CEO of Moderna says it's how many times you will need a Covid vaccine.
These reminder fires can also protect you from the flu.
During his CNBC interview, Bond also revealed thatBoosters in the future could make dual service. "What we are trying to do to moderna is trying to get an influenza vaccine in the clinic this year, then combine our flu vaccine at our Covid vaccine, so it's enough to get a boost. At your local CVS store ... Each year this would protect you with the variant concern against Covid and the season of seasonal flu, "said Bondel.
It hopes that the influenza of Moderna influenza vaccine will be able to provide better protection than the current one between 40 and 60%.Rate of efficiency depending on the year, according to the CDC. And for more on what could affect the quality of your vaccine, checkThis common medicine can make your vaccine less efficient, the study says.
Moderna will soon test its vaccine on people under 18 years old.
Currently, the Moderna vaccine is only allowed for those aged 18 and over. However, the company is also working on the modification of this. Moderna also announced on April 13 that its phase 2/3 Study of Teencove is entirely registered, which will test the vaccine on adolescents aged 12 to 17 years. There are about 3,000 participants from the United States enrolled in this new trial.
The Company also announced that they currently included participants for a trial that will test the 6-month-old vaccine. And for more COVID vaccine information up to date,Sign up for our daily newsletter.
Pfizer has recently reported similar updated efficiency results for its vaccine.
Pfizer has published a statement on April 1, confirming that its Covid vaccineremains very effective and safeFor at least six months after the second dose too.Researchers for PfizerData analyzed on more than 46,000 test participants and found that on 927 participants who were infected with COVID more than a week after their second dose, only 77 had received the real vaccine that 850 who had received a placebo . According to the study, the Pfizer vaccine is 91.3% effective against symptomatic covidation cases and 95.3 to 100% in effect against serious COVIDs six months after your vaccination totally vaccinated. And for more than this vaccine, checkPfizer has provoked this reaction in half of the recipients, the new study indicates.